BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2009
View Archived Issues
Data on evaluation of rivastigmine clinical safety and efficacy disclosed at ICAD
Read More
Inovio reports results from animal studies of H1N1 influenza vaccines
Read More
Medicis and Revance sign license agreement for neurotoxin RT-002
Read More
Novel kinase inhibitors claimed by Bayer Schering Pharma for cancer
Read More
Cascade Therapeutics describes 5-HT2C receptor agonists for obesity and other diseases
Read More
Janssen discloses NPY Y2 antagonists for the treatment of alcoholism
Read More
AMPA glutamate receptor agonists in development at GSK for treatment of schizophrenia
Read More
Cascade Therapeutics presents novel compounds for the treatment of epilepsy
Read More
MSM and Merck Serono collaborate to create antibody-based products targeted to GPCRs
Read More
FDA accepts Roche's complete response resubmission of the Actemra BLA for RA
Read More
FDA advisory committee recommends Schering-Plough's Saphris for bipolar I disorder
Read More
GTAC issues favorable opinion on ReNeuron's phase I clinical trial of Re-N001 in stroke
Read More
Zogenix and Astellas sign exclusive U.S. copromotion agreement for Sumavel DosePro
Read More
ACT Biotech initiates treatment in phase II clinical trial of telatinib in gastric cancer
Read More
Repros suspends dosing of Proellex in clinical trials
Read More
Invega Sustenna approved for acute and maintenance schizophrenia treatment
Read More
FDA approves Livalo for primary hypercholesterolemia and dyslipidemia
Read More
Opioid antagonist naltrexone reduces stealing urges in adult kleptomaniacs
Read More
Cx-401 is safe and effective in the treatment of complex perianal fistulas in phase II trial
Read More
Placenta-derived adherent stromal cells, PLX, effective in animal model of limb ischemia
Read More
HCV vaccine IC-41 add-on therapy induces T-cell response but does not prevent relapse
Read More
Amgen reports top-line results for denosumab trial in bone metastases
Read More
The European Commission approves Otsuka's Samsca
Read More
Micromet receives European orphan drug designation for blinatumomab
Read More
Astellas to file an NDA in Japan for XP-13512 in RLS
Read More